Legend Biotech Corp (LEGN) Return on equity 2020–2024
Legend Biotech Corp (LEGN) return on equity by fiscal year — reported net income divided by year-end shareholders’ equity.
-17.0%FY2024 · since FY2020: -44.6% → -17.0%
| Fiscal year | Value | YoY |
|---|---|---|
| FY2024 | -17.0% | +24.4 pp |
| FY2023 | -41.4% | +18.6 pp |
| FY2022 | -60.0% | -7.3 pp |
| FY2021 | -52.7% | -8.1 pp |
| FY2020 | -44.6% | — |
ROE = reported net income ÷ reported year-end shareholders’ equity for the same fiscal year. Heavy buybacks shrink equity and can push ROE very high (or negative-equity years drop out).
Source: SEC XBRL filings · For reference only · Not investment advice